Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures.
During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing Regulatory Science for Medical Countermeasure Development examines current medical countermeasures, and investigates the future of research and development in this area. Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools.
Advancing Regulatory Science for Medical Countermeasure Development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations.
Table of Contents |
skim chapter | |
|---|---|---|
| Front Matter | i-xviii | |
| 1 Introduction | 1-14 | |
| 2 MCM Enterprise and Stakeholder Perspectives | 15-28 | |
| 3 Cutting-Edge Efforts to Advance MCM Regulatory Science | 29-64 | |
| 4 MCM Regulatory Science Needs for At-Risk Populations | 65-70 | |
| 5 Crosscutting Themes and Future Directions | 71-78 | |
| 6 Closing Remarks | 79-80 | |
| References | 81-82 | |
| Appendix A: Workshop Agenda | 83-98 | |
| Appendix B: Participant Biographies | 99-132 | |
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
E-mail: info@copyright.com
Web: https://www.copyright.com
Loading stats for Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary...
Finding similar items...
